1599eTiP PTT-4256-01: A modular, open label, dose finding phase I/II clinical trial in patients with solid tumours to assess the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of PTT-4256 (RAISIC-1)